We could not find any results for:
Make sure your spelling is correct or try broadening your search.
Trade like a pro: Leverage real-time discussions and market-moving ideas to outperform.
The current QLGN market cap is 3.13M. The company's latest EPS is USD -18.2190 and P/E is -0.02.
| Quarter End | Sep 2023 | Dec 2023 | Mar 2024 | Jun 2024 | Sep 2024 |
|---|---|---|---|---|---|
| USD (US$) | USD (US$) | USD (US$) | USD (US$) | USD (US$) | |
| Total Revenue | 0 | 0 | 0 | 0 | 0 |
| Operating Income | -1.15M | -2.27M | -1.42M | -1.75M | -1.26M |
| Net Income | -3.66M | -2.45M | -2.03M | -1.58M | -1.88M |
| Year End December 30 2023 | 2019 | 2020 | 2021 | 2022 | 2023 |
|---|---|---|---|---|---|
| USD (US$) | USD (US$) | USD (US$) | USD (US$) | USD (US$) | |
| Total Revenue | 0 | 2.85M | 5.65M | 4.98M | 0 |
| Operating Income | -10.84M | -11.9M | -22.66M | -22.18M | -11.31M |
| Net Income | -10.13M | -19.55M | -17.9M | -18.64M | -13.42M |
| Quarter End | Sep 2023 | Dec 2023 | Mar 2024 | Jun 2024 | Sep 2024 |
|---|---|---|---|---|---|
| USD (US$) | USD (US$) | USD (US$) | USD (US$) | USD (US$) | |
| Total Assets | 4.32M | 2.03M | 1M | 534k | 2.31M |
| Total Liabilities | 5.96M | 4.14M | 4.53M | 4.81M | 4.45M |
| Total Equity | -1.64M | -2.1M | -3.52M | -4.28M | -2.14M |
| Year End December 30 2023 | 2019 | 2020 | 2021 | 2022 | 2023 |
|---|---|---|---|---|---|
| USD (US$) | USD (US$) | USD (US$) | USD (US$) | USD (US$) | |
| Total Assets | 2.8M | 29.13M | 22.84M | 19.08M | 2.03M |
| Total Liabilities | 1.7M | 10.83M | 6.27M | 10.32M | 4.14M |
| Total Equity | 1.1M | 18.3M | 16.57M | 8.77M | -2.1M |
| Quarter End | Sep 2023 | Dec 2023 | Mar 2024 | Jun 2024 | Sep 2024 |
|---|---|---|---|---|---|
| USD (US$) | USD (US$) | USD (US$) | USD (US$) | USD (US$) | |
| Operating | -4.63M | -10.3M | -784k | -2.26M | -4.06M |
| Investing | 3.98M | 4.22M | N/A | 350k | -900k |
| Financing | -440k | -550k | 475k | 1.63M | 4.94M |
| Year End December 30 2023 | 2019 | 2020 | 2021 | 2022 | 2023 |
|---|---|---|---|---|---|
| USD (US$) | USD (US$) | USD (US$) | USD (US$) | USD (US$) | |
| Operating | -14.52M | -10.16M | -14.73M | -13.25M | -10.3M |
| Investing | 7M | -64k | -141k | -184k | 4.22M |
| Financing | 1.41M | 34.05M | 8.43M | 2.91M | -550k |
| Market Cap | 3.13M |
| Price to Earnings Ratio | -0.02 |
| Price to Sales Ratio | 0 |
| Price to Cash Ratio | 0.82 |
| Price to Book Ratio | -0.16 |
| Dividend Yield | - |
| Shares Outstanding | 736.43k |
| Average Volume (1 week) | 10.53k |
| Average Volume (1 Month) | 19.5k |
| 52 Week Change | -82.76% |
| 52 Week High | 29.435 |
| 52 Week Low | 3.3358 |
| Spread (Intraday) | 0.51 (11.02%) |
| Company Name | Qualigen Therapeutics Inc |
| Address |
251 little falls drive wilmington, delaware 19808 |
| Website | https://www.qualigeninc.com |
| Industry | pharmaceutical preparations (2834) |
It looks like you are not logged in. Click the button below to log in and keep track of your recent history.
Support: +44 (0) 203 8794 460 | support@advfn.com
By accessing the services available at ADVFN you are agreeing to be bound by ADVFN's Terms & Conditions
Hot Features
Premium
